Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Jun 2;20(9):1426–1434. doi: 10.1016/j.bbmt.2014.05.023

Figure 3.

Figure 3

Incidence of graft-verus-host disease in study (n=34) and contemporaneous control (n=26) patients. (A) Cumulative incidence of grade 2–4 acute GVHD. Study versus control, p=0.08. (B) Cumulative incidence of grade 3–4 acute GVHD. Study versus control, p=0.05. (C) Cumulative incidence of moderate-to-severe chronic GVHD. Study versus control, p=0.4. Dashed line, contemporaneous control patients; Solid line, study patients treated with etanercept.